The large block sale by BVF Partners and concurrent heavy selling by the CEO and CFO suggest a lack of confidence in near-term catalysts. Traders should watch for upcoming clinical data or earnings announcements that could explain the insider selling. The stock may face near-term pressure, but the strong analyst consensus (93% bullish) provides a counterbalance.
Price Chart
Executive Summary
Kymera Therapeutics (KYMR) saw a massive insider selling cluster over the past week, with total open-market sales exceeding $109 million, including a $89.2 million block sale by director BVF Partners. The CEO and CFO sold approximately $9.2M and $8.9M, respectively, after exercising options. This represents about 1.2% of the company's $9.4B market cap, a significant insider outflow that warrants caution given the lack of disclosed positive catalysts.
Key Financial Metrics
Key Facts
- CEO Nello Mainolfi sold ~$9.2M in open-market shares (80,000 shares) on July 1, 2026, after exercising options.
- CFO Bruce Jacobs sold ~$8.9M in open-market shares (77,109 shares) on June 30, 2026, after exercising options.
- Director BVF Partners (Booth Bruce) sold $89.2M in a single block trade on June 26, 2026.
- Total insider selling exceeds $109M, or ~1.2% of the $9.4B market cap.
- Net direction is overwhelmingly selling, with no insider purchases in the cluster.
Financial Impact
Total insider selling of ~$109M, about 1.2% of market cap, concentrated among top executives and a major director.
Risk Factors
- Insider selling could signal undisclosed negative news or a peak in the stock price.
- The BVF sale may represent a strategic exit, reducing a major insider's stake.
- Option exercises followed by sales are often routine, but the magnitude here is outsized.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KYMR-1783033308016 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 14w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access